Sexual and reproductive health needs and practices of female sex workers in Papua New Guinea: findings from a biobehavioral survey Kauntim mi tu ('Count me too').

Antenatal care Female sex workers HIV Moderately or highly effective contraception Papua New Guinea Sexual and reproductive health

Journal

Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826

Informations de publication

Date de publication:
05 Sep 2022
Historique:
received: 05 05 2022
accepted: 24 06 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 6 9 2022
Statut: epublish

Résumé

Little research has explored the sexual and reproductive health (SRH) experience of female sex workers (FSW), including girls aged < 18 years who are commercially sexually exploited (CSE), in Papua New Guinea (PNG). This paper describes the SRH history of FSW and CSE girls and factors associated with their use of moderately or highly effective contraceptive methods in three settings in PNG. From 2016 to 2017, respondent-driven sampling (RDS) surveys were conducted among FSW and CSE girls in Port Moresby, Lae, and Mt. Hagen. FSW and CSE girls who were born female, aged ≥12 years, sold or exchanged vaginal sex in the past 6 months, spoke English or Tok Pisin, and had a valid RDS study coupon were eligible to participate. Interviews were conducted face-to-face and participants were offered rapid routine HIV and syphilis testing. Survey logistic regression procedures were used to identify factors associated with the use of moderately or highly effective contraceptive methods. Weighted data analysis was conducted. A total of 2901 FSW and CSE girls (Port Moresby, 673; Lae, 709; and Mt. Hagen, 709) were enrolled. The proportion using moderately or highly effective contraceptive methods was 37.7% in Port Moresby, 30.9% in Lae, and 26.5% in Mt. Hagen. After adjusting for covariates, factors significantly associated with the use of moderately or highly effective contraceptive methods in Port Moresby were being age 20-24, being married, being divorced or separated, having one or more dependent children, being away from home for more than 1 month in the last 6 months, and having tested HIV negative. No factors were significantly associated in Lae or Mt. Hagen. ANC attendance amongst FSW and CSE girls who gave birth in last 3 years was highest in Port Moresby at 91.2%. HIV testing was inconsistently and inadequately offered at ANC across the three cities. Kauntim mi tu provides much-needed insight into the SRH experiences of FSW and CSE girls in PNG, where their use of moderately or highly effective contraceptive methods is low. We hope to shed light on the complicated reality they face due to illegality of sex work and multitude of complex healthcare experiences.

Sections du résumé

BACKGROUND BACKGROUND
Little research has explored the sexual and reproductive health (SRH) experience of female sex workers (FSW), including girls aged < 18 years who are commercially sexually exploited (CSE), in Papua New Guinea (PNG). This paper describes the SRH history of FSW and CSE girls and factors associated with their use of moderately or highly effective contraceptive methods in three settings in PNG.
METHODS METHODS
From 2016 to 2017, respondent-driven sampling (RDS) surveys were conducted among FSW and CSE girls in Port Moresby, Lae, and Mt. Hagen. FSW and CSE girls who were born female, aged ≥12 years, sold or exchanged vaginal sex in the past 6 months, spoke English or Tok Pisin, and had a valid RDS study coupon were eligible to participate. Interviews were conducted face-to-face and participants were offered rapid routine HIV and syphilis testing. Survey logistic regression procedures were used to identify factors associated with the use of moderately or highly effective contraceptive methods. Weighted data analysis was conducted.
RESULTS RESULTS
A total of 2901 FSW and CSE girls (Port Moresby, 673; Lae, 709; and Mt. Hagen, 709) were enrolled. The proportion using moderately or highly effective contraceptive methods was 37.7% in Port Moresby, 30.9% in Lae, and 26.5% in Mt. Hagen. After adjusting for covariates, factors significantly associated with the use of moderately or highly effective contraceptive methods in Port Moresby were being age 20-24, being married, being divorced or separated, having one or more dependent children, being away from home for more than 1 month in the last 6 months, and having tested HIV negative. No factors were significantly associated in Lae or Mt. Hagen. ANC attendance amongst FSW and CSE girls who gave birth in last 3 years was highest in Port Moresby at 91.2%. HIV testing was inconsistently and inadequately offered at ANC across the three cities.
CONCLUSIONS CONCLUSIONS
Kauntim mi tu provides much-needed insight into the SRH experiences of FSW and CSE girls in PNG, where their use of moderately or highly effective contraceptive methods is low. We hope to shed light on the complicated reality they face due to illegality of sex work and multitude of complex healthcare experiences.

Identifiants

pubmed: 36064615
doi: 10.1186/s13690-022-00926-y
pii: 10.1186/s13690-022-00926-y
pmc: PMC9442976
doi:

Types de publication

Journal Article

Langues

eng

Pagination

202

Subventions

Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : US Centers for Disease Control and Prevention
ID : NU2GGH002093-01-00
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15
Organisme : Cardno
ID : U2GGH001531-01531GH15

Informations de copyright

© 2022. The Author(s).

Références

JMIR Public Health Surveill. 2019 Mar 21;5(1):e11285
pubmed: 30896432
JMIR Public Health Surveill. 2020 Nov 17;6(4):e21688
pubmed: 33200996
J Fam Plann Reprod Health Care. 2017 Jan;43(1):50-59
pubmed: 26609081
Sci Rep. 2021 Jan 13;11(1):1222
pubmed: 33441569
Reprod Health. 2018 Sep 21;15(1):158
pubmed: 30241542
AIDS Behav. 2021 May;25(5):1573-1582
pubmed: 32761475
Sex Health. 2008 Mar;5(1):9-16
pubmed: 18361849
Int J Womens Health. 2011 Feb 15;3:53-61
pubmed: 21445375
BMC Public Health. 2019 May 22;19(1):623
pubmed: 31117978
Global Health. 2014 Jun 10;10:46
pubmed: 24916010
BMJ Open. 2018 Apr 24;8(4):e019006
pubmed: 29691241
PLoS One. 2020 Apr 29;15(4):e0231181
pubmed: 32348303
Sex Health. 2020 Aug;17(4):311-320
pubmed: 32698941
AIDS Care. 2017 Jun;29(6):675-685
pubmed: 27998178
Int J Health Plann Manage. 2018 Jan;33(1):e367-e377
pubmed: 28960552
BMC Public Health. 2020 Jun 26;20(1):1015
pubmed: 32590975
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
PLoS One. 2020 May 15;15(5):e0233026
pubmed: 32413084
Sex Reprod Health Matters. 2019 Dec;27(1):1686199
pubmed: 31790637
Contracept Reprod Med. 2019 Feb 15;4:3
pubmed: 30783537
Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):349-357
pubmed: 29383699
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S91-8
pubmed: 25723996
BMC Int Health Hum Rights. 2017 May 5;17(1):11
pubmed: 28476153
AIDS Behav. 2014 Mar;18(3):573-82
pubmed: 24264727
Stud Fam Plann. 2017 Jun;48(2):121-151
pubmed: 28422301
Sex Transm Infect. 2020 Mar;96(2):143-150
pubmed: 31182653
Clin Microbiol Infect. 2019 May;25(5):623-627
pubmed: 30107282

Auteurs

Damian Weikum (D)

US Centers for Disease Control and Prevention, Atlanta, USA. ndi9@cdc.gov.
Public Health Institute, Oakland, USA. ndi9@cdc.gov.

Angela Kelly-Hanku (A)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Public Health Intervention Research Program, Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW, Australia.

Ruthy Neo-Boli (R)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Herick Aeno (H)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Steven G Badman (SG)

Public Health Intervention Research Program, Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW, Australia.

Lisa M Vallely (LM)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Public Health Intervention Research Program, Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW, Australia.

Barne Willie (B)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Martha Kupul (M)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Parker Hou (P)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Angelyn Amos (A)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Rebecca Narokobi (R)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Simon Pekon (S)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Kelsey Coy (K)

US Centers for Disease Control and Prevention, Atlanta, USA.

Johanna Wapling (J)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

Janet Gare (J)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

John M Kaldor (JM)

Public Health Intervention Research Program, Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW, Australia.

Andrew J Vallely (AJ)

Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.
Public Health Intervention Research Program, Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW, Australia.

Avi J Hakim (AJ)

US Centers for Disease Control and Prevention, Atlanta, USA.

Classifications MeSH